Cytotoxicity and Apoptosis Inducing Activities of 2-Amino-4H-chromene-3-carbonitrile Derivatives Loaded on Gold Nanoparticles Against Human Breast Cancer Cell Line T47D

[1]  A. Akbarzadeh,et al.  Synthesis of Gold Nanoparticles Coated with Aspartic Acid and Their Conjugation with FVIII Protein and FVIII Antibody , 2014, Indian Journal of Clinical Biochemistry.

[2]  Baoan Chen,et al.  Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles , 2011, International journal of nanomedicine.

[3]  William E. Kemnitzer,et al.  Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. , 2008, Bioorganic & medicinal chemistry letters.

[4]  Lionel Tarassenko,et al.  Chemotherapy side-effect management using mobile phones , 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[5]  H. Coley.  Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. , 2008, Cancer treatment reviews.

[6]  William E. Kemnitzer,et al.  Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of N-alkyl substituted pyrrole fused at the 7,8-positions. , 2008, Journal of medicinal chemistry.

[7]  William E. Kemnitzer,et al.  Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7,8-positions. , 2007, Journal of medicinal chemistry.

[8]  F. Gao,et al.  The in vitro inhibition of multidrug resistance by combined nanoparticulate titanium dioxide and UV irradition. , 2006, Biomaterials.

[9]  Yong Sup Lee,et al.  Synthesis and anticancer activity of lavendustin A derivatives containing arylethenylchromone substituents. , 2006, European journal of medicinal chemistry.

[10]  William E. Kemnitzer,et al.  Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions. , 2005, Bioorganic & medicinal chemistry letters.

[11]  D. Norris,et al.  BMC Biotechnology BioMed Central Methodology article A simple technique for quantifying apoptosis in 96-well plates , 2005 .

[12]  B. Choi,et al.  Role of ERK activation in cisplatin-induced apoptosis in A172 human glioma cells. , 2004, Neurotoxicology.

[13]  William E. Kemnitzer,et al.  Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. , 2004, Journal of medicinal chemistry.

[14]  H. Gourdeau,et al.  Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents. , 2004, Molecular cancer therapeutics.

[15]  Chad A Mirkin,et al.  Bio-bar-code-based DNA detection with PCR-like sensitivity. , 2004, Journal of the American Chemical Society.

[16]  D. Astruc,et al.  Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum‐Size‐Related Properties, and Applications Toward Biology, Catalysis, and Nanotechnology. , 2004 .

[17]  James H Thrall,et al.  Nanotechnology and medicine. , 2004, Radiology.

[18]  C. Mirkin,et al.  Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins , 2003, Science.

[19]  S. Singletary.  Rating the Risk Factors for Breast Cancer , 2003, Annals of surgery.

[20]  L. O’Driscoll,et al.  Survivin: role in normal cells and in pathological conditions. , 2003, Current cancer drug targets.

[21]  Elaine Merisko-Liversidge,et al.  Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  Oliver Kayser,et al.  Leishmanicidal and antiplasmodial activity of constituents of Smirnowia iranica. , 2002, Journal of natural products.

[23]  K. Al-Sakkaf,et al.  Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells , 2002, British Journal of Cancer.

[24]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[25]  R. Gibb,et al.  Use of diphenylamine in the detection of apoptosis. , 2001, Methods in molecular medicine.

[26]  John Calvin Reed,et al.  Drug discovery opportunities from apoptosis research. , 2000, Current opinion in biotechnology.

[27]  Spratt Js,et al.  Assessing the risk of breast cancer. , 2000 .

[28]  J. Schulz,et al.  Neuroprotection by the Inhibition of Apoptosis , 2000, Brain pathology.

[29]  P Couvreur,et al.  Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. , 2000, Biomaterials.

[30]  M. Blagosklonny,et al.  A node between proliferation, apoptosis, and growth arrest. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  J C Reed,et al.  Dysregulation of apoptosis in cancer. , 1998, The cancer journal from Scientific American.

[32]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[33]  P. Couvreur,et al.  On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance , 1996, Cancer Chemotherapy and Pharmacology.

[34]  C. Winterford,et al.  Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.

[35]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[36]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.